Molecular neurobiology and promising new treatment in depression

Sang Won Jeon, Yong Ku Kim

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The limited effects of currently available antidepressants are becoming an urgent issue in depression research. It takes a long time to determine treatment effects, and the overall remission rate is low. Although we expect the development of non-monoamine antidepressants in the near future, efforts in this regard over the past several decades have not yet been compensated. Thus, researchers and clinicians should clarify the neurobiological mechanisms of integrated modulators that regulate changes in genes, cells, the brain, and behaviors associated with depression. In this study, we review molecular neurobiological theories and new treatments for depression. Beyond neuroanatomy and monoamine theory, we discuss cells and molecules, neural plasticity, neurotrophisms, endocrine mechanisms, immunological mechanisms, genetics, circadian rhythms, and metabolic regulation in depression. In addition, we introduce the possibility of new antidepressant drug development using protein translation signaling (mTOR) pathways.

Original languageEnglish
Article number381
JournalInternational Journal of Molecular Sciences
Volume17
Issue number3
DOIs
Publication statusPublished - 2016 Mar 15

Fingerprint

Neurobiology
Modulators
Antidepressive Agents
Plasticity
Brain
Genes
Proteins
Molecules
Neuroanatomy
Neuronal Plasticity
circadian rhythms
Protein Biosynthesis
Circadian Rhythm
molecular theory
Therapeutics
cells
Research Personnel
plastic properties
genes
brain

Keywords

  • Antidepressant
  • BDNF
  • Depression
  • Endocrine
  • Gene
  • Immune
  • MTOR
  • Neural plasticity
  • Neurobiology

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Molecular neurobiology and promising new treatment in depression. / Jeon, Sang Won; Kim, Yong Ku.

In: International Journal of Molecular Sciences, Vol. 17, No. 3, 381, 15.03.2016.

Research output: Contribution to journalArticle

@article{c178e5b4dc044b5dba137301a1346aa1,
title = "Molecular neurobiology and promising new treatment in depression",
abstract = "The limited effects of currently available antidepressants are becoming an urgent issue in depression research. It takes a long time to determine treatment effects, and the overall remission rate is low. Although we expect the development of non-monoamine antidepressants in the near future, efforts in this regard over the past several decades have not yet been compensated. Thus, researchers and clinicians should clarify the neurobiological mechanisms of integrated modulators that regulate changes in genes, cells, the brain, and behaviors associated with depression. In this study, we review molecular neurobiological theories and new treatments for depression. Beyond neuroanatomy and monoamine theory, we discuss cells and molecules, neural plasticity, neurotrophisms, endocrine mechanisms, immunological mechanisms, genetics, circadian rhythms, and metabolic regulation in depression. In addition, we introduce the possibility of new antidepressant drug development using protein translation signaling (mTOR) pathways.",
keywords = "Antidepressant, BDNF, Depression, Endocrine, Gene, Immune, MTOR, Neural plasticity, Neurobiology",
author = "Jeon, {Sang Won} and Kim, {Yong Ku}",
year = "2016",
month = "3",
day = "15",
doi = "10.3390/ijms17030381",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Molecular neurobiology and promising new treatment in depression

AU - Jeon, Sang Won

AU - Kim, Yong Ku

PY - 2016/3/15

Y1 - 2016/3/15

N2 - The limited effects of currently available antidepressants are becoming an urgent issue in depression research. It takes a long time to determine treatment effects, and the overall remission rate is low. Although we expect the development of non-monoamine antidepressants in the near future, efforts in this regard over the past several decades have not yet been compensated. Thus, researchers and clinicians should clarify the neurobiological mechanisms of integrated modulators that regulate changes in genes, cells, the brain, and behaviors associated with depression. In this study, we review molecular neurobiological theories and new treatments for depression. Beyond neuroanatomy and monoamine theory, we discuss cells and molecules, neural plasticity, neurotrophisms, endocrine mechanisms, immunological mechanisms, genetics, circadian rhythms, and metabolic regulation in depression. In addition, we introduce the possibility of new antidepressant drug development using protein translation signaling (mTOR) pathways.

AB - The limited effects of currently available antidepressants are becoming an urgent issue in depression research. It takes a long time to determine treatment effects, and the overall remission rate is low. Although we expect the development of non-monoamine antidepressants in the near future, efforts in this regard over the past several decades have not yet been compensated. Thus, researchers and clinicians should clarify the neurobiological mechanisms of integrated modulators that regulate changes in genes, cells, the brain, and behaviors associated with depression. In this study, we review molecular neurobiological theories and new treatments for depression. Beyond neuroanatomy and monoamine theory, we discuss cells and molecules, neural plasticity, neurotrophisms, endocrine mechanisms, immunological mechanisms, genetics, circadian rhythms, and metabolic regulation in depression. In addition, we introduce the possibility of new antidepressant drug development using protein translation signaling (mTOR) pathways.

KW - Antidepressant

KW - BDNF

KW - Depression

KW - Endocrine

KW - Gene

KW - Immune

KW - MTOR

KW - Neural plasticity

KW - Neurobiology

UR - http://www.scopus.com/inward/record.url?scp=84961251622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961251622&partnerID=8YFLogxK

U2 - 10.3390/ijms17030381

DO - 10.3390/ijms17030381

M3 - Article

C2 - 26999106

AN - SCOPUS:84961251622

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 3

M1 - 381

ER -